Development of antibodies to disrupt FXIII/fibrinogen interactions for venous thrombosis prevention Development of antibodies to disrupt FXIII/fibrinogen interactions for venous thrombosis prevention Jenni Thomas / Monday, June 24, 2024 0 382 Article rating: No rating Monday, June 24, 2024 June 24, 2024 | Kadri Kangro, Ph.D.; University of North Carolina; Chapel Hill, NC, U.S. Read more
G6b-B bi-specific cis-acting platelet receptor inhibitors (CAPRIs) – a novel therapy in thrombosis G6b-B bi-specific cis-acting platelet receptor inhibitors (CAPRIs) – a novel therapy in thrombosis Jenni Thomas / Monday, June 24, 2024 0 679 Article rating: No rating Monday, June 24, 2024 June 24, 2024 | Amrita Sarkar, Ph.D.; Children’s Hospital of Philadelphia; Philadelphia, PA, U.S. Read more
Turning back the clock: ISTH staff member Cary Clark shares his most memorable moments Turning back the clock: ISTH staff member Cary Clark shares his most memorable moments Jenni Thomas / Monday, June 24, 2024 0 1026 Article rating: No rating Monday, June 24, 2024 Read more
Receptor-bound plasminogen impacts on early platelet deposition and fibrin accumulation Receptor-bound plasminogen impacts on early platelet deposition and fibrin accumulation Jenni Thomas / Monday, June 24, 2024 0 316 Article rating: No rating Monday, June 24, 2024 June 24, 2024 | Claire Whyte, Ph.D., B.Sc.; University of Aberdeen; Aberdeen, U.K. Read more
Croatia to host upcoming ISTH Workshop on Hemostatic Disorders in September Croatia to host upcoming ISTH Workshop on Hemostatic Disorders in September Jenni Thomas / Monday, June 24, 2024 0 821 Article rating: No rating Monday, June 24, 2024 Read more